Director, Clinical Pharmacology
Verastem Inc - Boston, Massachusetts
Posted Oct 30, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- Not verified
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $81,444 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +6.9% - Faster than average
Matched to SOC 29-1141 - Healthcare aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Director, Clinical Pharmacology Boston, Massachusetts Company Profile: At Verastem Oncology, we address urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We've launched this novel/novel combination therapy in the U.S. and are exploring pathways for Europe and Japan. We continue to advance our pipeline of drugs to help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. This is an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients. Position Summary Lead clinical pharmacology and model informed drug development (MIDD) for small molecule oncology programs from first-in-human studies through registration. Integrate nonclinical, translational, and clinical evidence to guide study design, dose and regimen optimization, and regulatory decisions. This role owns clinical pharmacology strategy and study support, partnering closely with pharmacometricians on modeling and simulation. The position is expected to align primarily with Director or Senior Director scope; experienced Associate Director candidates will be considered. Key Responsibilities Set integrated clinical pharmacology and MIDD strategy for one or more programs, including first in human dosing, escalation, dose optimization, combinations, and registration planning. Design and oversee clinical pharmacology studies and assessments, including PK/PD and biomarker sampling, food effect, bioavailability and bioequivalence, formulation bridging, drug interactions, organ impairment, and other special populations. Lead
Read the full description at verastem.bamboohr.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Director, Development Strategy and Operations, Clinical Development
Verastem Inc - Boston, Massachusetts
Director, Clinical Pharmacology
Bristol Myers Squibb - Princeton - NJ - US
Senior Director, Clinical Pharmacology
Keros Therapeutics Inc - Lexington, MA (Hybrid)
Director, Clinical Sciences
Tango Therapeutics Inc - Boston, MA